Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
039840.KQ
HoldUnloved QualityDIO Corporation · Healthcare · South Korea · $104M · Avg Vol: $203K/d
COMPANY DESCRIPTION
DIO Corporation manufactures and sells dental implants in South Korea and internationally. The company offers UFII implant internal submerged and no-submerged systems, FTN implant external systems, protem implants, and UV active implant systems.
FINANCIAL SUMMARY (KRW)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2026E | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 131.3B | 155.8B | 119.6B | 164.1B | 7.7% | 173.4B | 188.1B | 238.5B | 20.6% |
| EPS (KRW) | -1,380 | 227.00 | -2,865 | -100.00 | — | -99.39 | — | — | — |
| Shares | 14.7M | 14.5M | 13.9M | 13.2M | -10.6% | 12.9M | — | — | — |
| Debt | 116.0B | 118.1B | 84.9B | 80.9B | -11.3% | 82.7B | — | — | — |
| Equity | 165.9B | 194.4B | 204.1B | 191.7B | 4.9% | — | — | — | — |
| Op CF | -1.0B | 5.4B | 14.7B | 16.6B | 74.6% | 24.0B | — | — | — |
| Inv CF | -16.6B | -2.9B | -21.2B | 19.2B | — | — | — | — | — |
| Fin CF | 5.1B | -10.3B | 20.2B | -18.6B | — | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 039840.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 039840.KQ | DIO Corporation(you) | $104M | 50 | Hold |
| 303810.KQ | DK Life Science Co., Ltd. | $53M | 50 | Hold |
| 489460.KQ | BIOBIJOU Co.,Ltd. | $126M | 64 | Hold |
| 099430.KQ | Bio Plus Co., Ltd | $156M | 39 | Hold |
| 145720.KS | Dentium CO., LTD | $240M | 54 | Hold |
| 179290.KQ | M.I.TECH Co.,Ltd | $124M | 76 | Buy |
| 119610.KQ | Interojo Inc. | $114M | 81 | Strong Buy |
| 216080.KQ | JETEMA, Co., Ltd. | $130M | 12 | Strong Sell |
| 314930.KQ | Biodyne Co., Ltd. | $157M | 9 | Strong Sell |
| 219750.KQ | BTB Korea Co.,Ltd | $95M | 3 | Strong Sell |
Peer medians: ROE -0.3% · P/E 16.1x · Gross margin 43.0%